Erytech Pharma SA Sponsored ADR - 48 Year Dividend History | ERYP

Historical dividend payout and yield for Erytech Pharma SA Sponsored ADR (ERYP) since 1971. The current TTM dividend payout for Erytech Pharma SA Sponsored ADR (ERYP) as of May 17, 2019 is $0.00. The current dividend yield for Erytech Pharma SA Sponsored ADR as of May 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.129B $0.000B
Erytech Pharma S.A. operates as a biopharmaceutical company. It discovers and developes therapies for rare forms of cancer and orphan diseases. The company's product pipeline consists of eryaspase, erymethionase, eryminase, ERYZYME and ERYMMUNE which are in clinical stages. It operates primarily in France and the United States. Erytech Pharma S.A. is based in France.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $103.634B 11.72
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.478B 51.02